metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Bilateral symmetrical adrenal hypermetabolism on FDG PET/CT due to Cushing syndr...
Journal Information
Vol. 35. Issue 2.
Pages 118-120 (March - April 2016)
Share
Share
Download PDF
More article options
Visits
38
Vol. 35. Issue 2.
Pages 118-120 (March - April 2016)
Clinical note
Bilateral symmetrical adrenal hypermetabolism on FDG PET/CT due to Cushing syndrome in well differentiated neuroendocrine carcinoma
Hipermetabolismo suprarrenal bilateral simétrico en FDG PET/TC por síndrome de Cushing en un carcinoma neuroendocrino bien diferenciado
Visits
38
G.E. Aktas
Corresponding author
dr.gulege@yahoo.com

Corresponding author.
, S. Soyluoglu Demir, A. Sarikaya
Trakya University Medical Faculty Hospital, Department of Nuclear Medicine, Turkey
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Abstract

The 18F-FDG PET/CT scan has been suggested for whole-body imaging to identify ectopic adrenocorticotrophic hormone secreting tumours, but there are some challenges involved. The case of a patient is presented, who was admitted with the pre-diagnosis of ectopic ACTH syndrome. On the CT, a nodular lesion was detected in the medial segment of the right lung. The FDG uptake of the lesion seemed to be increased visually, but was not pathological quantitatively (SUVmax: 1.8) on the PET/CT. There was also diffuse increased uptake (SUVmax: 14.2) in the enlarged adrenal glands. The lesion was reported as a possible malignant lesion with low FDG affinity, such as a low grade neuroendocrine tumour, while the diffuse enlarged adrenal glands with high uptake were interpreted as diffusely hyperplasic, due to Cushing's syndrome. The patient was treated with a surgical wedge resection. The histopathological diagnosis confirmed that the tumour was a grade 1 well-differentiated neuroendocrine carcinoma.

Keywords:
18F-FDG PET/CT
Neuroendocrine carcinoma
Bilateral adrenal hyperplasia
Cushing's syndrome
Adrenal metastasis
PET
Resumen

Se ha sugerido el uso de la PET/TC con 18F-FDG para la identificación de tumores que producen secreción ectópica de ACTH, pero ello conlleva algunos retos. Presentamos el caso de un paciente hospitalizado con el diagnóstico de sospecha de síndrome de ACTH ectópica. En la TC se detectó una lesión nodular en el segmento medial del pulmón derecho. La captación de FDG por la lesión parecía aumentada visualmente en la PET/TC, pero no alcanzó rango patológico cuantitativamente (SUV máx: 1,8). Había también una hipercaptación difusa (SUVmáx: 14,2) en las suprarrenales aumentadas de tamaño. La lesión pulmonar fue informada como posible lesión maligna de baja afinidad por la FDG, tal como un tumour neuroendocrino de bajo grado, mientras que las suprarrenales aumentadas y difusamente hipercaptantes fueron interpretadas como hiperplasia difusa por Síndrome de Cushing. El paciente fue tratado quirúrgicamente mediante una resección en cuña: el diagnóstico histopatológico confirmó un carcinoma neuroendocrino grado 1 bien diferenciado.

Palabras clave:
18F-FDG PET/TC
Carcinoma neuroendocrino
Hiperplasia adrenal bilateral
Síndrome de Cushing
Metástasis adrenal
PET

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos